Podcast: CBD, THC, FDA – What You Need To Know About Cannabis And Its Regulation

AG
Akin Gump Strauss Hauer & Feld LLP

Contributor

Akin is a law firm focused on providing extraordinary client service, a rewarding environment for our diverse workforce and exceptional legal representation irrespective of ability to pay. The deep transactional, litigation, regulatory and policy experience we bring to client engagements helps us craft innovative, effective solutions and strategies.
In this episode, Akin Gump health care and life sciences partner Howard Sklamberg discusses the history and status of cannabis regulation and enforcement in the U.S., particularly of cannabidiol, or CBD.
United States Food, Drugs, Healthcare, Life Sciences

Subscribe to OnAir with Akin Gump via iTunes, SoundCloud, YouTube, Spotify and Google Play.

In this episode, Akin Gump health care and life sciences partner Howard Sklamberg discusses the history and status of cannabis regulation and enforcement in the U.S., particularly of cannabidiol, or CBD.

Among the topics covered:

  • THC vs. CBD, hemp vs. marijuana
  • CBD and the Controlled Substances Act
  • CBD: supplement, food additive or drug?
  • FDA regulation of  CBD.

Download PDF

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

Mondaq uses cookies on this website. By using our website you agree to our use of cookies as set out in our Privacy Policy.

Learn More